Class / Patent application number | Description | Number of patent applications / Date published |
544112000 | Triazine ring | 7 |
20110098467 | PYRROLO-TRIAZINE ANILINE COMPOUNDS USEFUL AS KINASE INHIBITORS - Compounds having the formula (I), | 04-28-2011 |
20130197219 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG - The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity. | 08-01-2013 |
20130225809 | PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS - This invention relates to pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis. | 08-29-2013 |
20150353566 | TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF - The present invention discloses triazine compounds of Formula II and a process to synthesize these compounds. Particularly, the invention provides one pot method to synthesize triazines nucleus, wherein the method comprises amination followed by using Leuckart reaction conditions of pyrrole/indole-2-carboxylates of Formula I to obtain corresponding triazine compounds of Formula II. | 12-10-2015 |
544113000 | 1,3,5-Triazine ring | 3 |
20130317217 | AFFINITY ADSORBENTS FOR FIBRINOGEN - For the separation, removal, isolation, purification, characterisation, identification or quantification of fibrinogen or a protein that is a fibrinogen analogue, an affinity adsorbent is used that is a compound of formula II | 11-28-2013 |
20140213784 | METHOD FOR THE PREPARATION OF SUBSTITUTED OXAZOLIDINONES - The present invention relates to methods for the preparation of a compound having the formula (X). Individual reaction steps as well as intermediates are additionally claimed. | 07-31-2014 |
20150065705 | TRIAZINONE COMPOUND AND T-TYPE CALCIUM CHANNEL INHIBITOR - There is provided a novel triazinone compound that has an excellent T-type voltage-dependent calcium channel inhibitory activity and is specifically useful for treatment of pain. A compound of Formula (I), a tautomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof: | 03-05-2015 |